MRGPRX2 antagonist (GSK/John Hopkins University)

N/A

Report date: 2025/03/20 15:01:39
NME

Base Information

Drug NameMRGPRX2 antagonist (GSK/John Hopkins University)
Drug Alias NameMRGPRX2 inhibitor (GSK/John Hopkins University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMRGPRX2 antagonists
TargetsMRGPRX2
Therapy Area/IndicationsMastocytosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline LlcJohns Hopkins University
Inactive CompaniesN/A
Active IndicationsMastocytosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A